Table 2 |
||
|
A survey of medical standards (level 2 and level 3) suggested or already implemented in tissue-based diagnosis |
||
|
Medical Standard (level 2) |
Criteria (level 3) |
International/national Action |
|
|
||
|
Disease order [41] |
Hierarchic, 1 – 10 |
Proposed |
|
Formal disease classification |
ICD-O, SNO-MED |
Accepted |
|
Disease/human classification |
Board discussion |
Accepted for tumours (WHO classification) |
|
Disease frequency |
Not evaluated, probably >2 per month |
Open |
|
Mandatory expert consultation |
Rare cancer, lymphoma |
Proposed |
|
Mandatory quality assurance |
Breast cancer, Hodgkin's disease |
Accepted |
|
Image handling, exchange by DICOM 3, HL 7 |
General & individual regulations |
Proposed |
|
HIS, RIS communication by DICOM 3, HL 7 |
General & individual regulations |
Proposed |
|
Expert communication guidelines |
4 – 8 images/case, <2 different magnifications/case, |
Proposed |
|
|
||
|
Virtual microscopy: |
||
|
|
||
|
Diagnosis/image properties |
>50 pixels/object, >40 objects/image, >256 × 256 image size |
Proposed |
|
Disease/image features |
Disease – associated texture, object, structure parameters |
Open |
|
Image quality measure |
Gray value deviation, image standardization (shading, gray value range, gradient) |
Open |
|
Screening/image size |
Texture features: crude screening Object/structure features: classical diagnosis (H&E) |
Open |
|
Diagnosis/colour space |
RGB space – classical diagnosis. HSI space – prognosis associated diagnosis, cancer scores (hormone receptor, Gleason, etc.) |
Open |
|
|
||
|
Kayser et al. Diagnostic Pathology 2008 3:17 doi:10.1186/1746-1596-3-17 |
||